Action Potential Duration (APD) Testing on hESC-Derived Cardiomyocytes by ChanTest Corporation
Manufacturer ChanTest Corporation
Evaluate compounds in human stem cell-derived, ventricular-type cardiomyocytes. Effects on action potential parameters are evaluated in single human cardiomyocytes using patch-clamp recording Benefits:
Human ion channels expressed in a native cardiac environment
Detects AP Prolongation (QT risk) and EADs (Torsade trigger)
Stable recordings at physiological temperature with minimal diffusion delays
Cost-effective
Rapid turnaround time
The supplier does not provide quotations for this product through SelectScience. Browse these related products instead
Related Products
.jpg.ashx?width=100&height=100&bgcolor=white)
Action Potential Duration (APD) Testing on hESC-Derived Cardiomyocytes
The supplier does not provide quotations for this particular product through SelectScience. You can search for similar products in our product directory.
Evaluate compounds in human stem cell-derived, ventricular-type cardiomyocytes. Effects on action potential parameters are evaluated in single human cardiomyocytes using patch-clamp recording
Benefits:
- Human ion channels expressed in a native cardiac environment
- Detects AP Prolongation (QT risk) and EADs (Torsade trigger)
- Stable recordings at physiological temperature with minimal diffusion delays
- Cost-effective
- Rapid turnaround time
Product Overview
Action Potential Duration (APD) Testing on hESC-Derived Cardiomyocytes
Manufacturer ChanTest Corporation
Be the first to review this product